1. Inhibitors of Cell Wall Synthesis
 Penicillin
 Natural penicillins
 Semisynthetic penicillins
 Extended-spectrum penicillins

2. Penicillins
 Low toxicity
 Effective derivatives created from manipulating drug’s
basic molecular structure
 Kills bacteria by preventing them from forming the
rigid cell wall
 Because human cells do not have cell walls, they are
not affected

3. Therapeutic Uses of Penicillins
 Abscesses
 Beta-hemolytic streptococcus
 Meningitis
 Otitis media
 Pneumonia
 Respiratory infections
 Tooth and gum infections
 Venereal diseases (syphilis and gonorrhea)
 Endocarditis due to streptococci

4. Penicillins’ Side Effects
 Diarrhea
 Allergies in 7% to 10% of population
Penicillins’ Dispensing Issues
 Take on an empty stomach
 Food slows absorption
 Acids in fruit juices or colas could deactivate the drug

5. The Structure of Penicillins

6. The Structure of Penicillins

7. Retention of Penicillin G

8. The Effect of Penicillinase on
Penicillins

9. b-Lactam Antibiotics
 Penicillin
 Penicilinase-resistant
penicillins
 Penicillins + b-
lactamase inhibitors
 Carbapenems
 Substitute a C for a S,
add a double bond
 Monobactam
 Single ring

10. Inhibitors of Cell Wall Synthesis
 Cephalosporins
 First-generation: Narrow spectrum, gram-
positive
 Second-generation: Extended spectrum includes
gram-negative
 Third-generation: Includes pseudomonads;
injected
 Fourth-generation: Oral

11.  First-generation
 Similar to penicillinase-resistant penicillins with greater gram-negative
coverage
 Used for
 community-acquired infections
 mild to moderate infections
 Second-generation
 Increased activity, especially against Haemophilus influenzae
 Used for
 Otitis media in children
 Respiratory infections
 UTIs
 Third-generation
 Active against a wide spectrum of gram-negative organisms
 Long half-life, so once-a-day dosing for some
 Used for
 Ambulatory patients
 Children (dosing before or after school)

12. Inhibitors of Cell Wall Synthesis
 Polypeptide antibiotics
 Bacitracin
 Topical application
 Against gram-positives
 Vancomycin
 Glycopeptide
 Important "last line" against antibiotic-resistant
S. aureus

13. Comparison of Cephalosporin and
Penicillin

14. The Inhibition of Protein Synthesis
by Antibiotics

15. Inhibitors of Protein Synthesis
 Chloramphenicol
 Broad spectrum
 Binds 50S subunit; inhibits peptide bond formation

16. Inhibitors of Protein Synthesis
 Aminoglycosides
 Streptomycin, neomycin, gentamycin
 Broad spectrum
 Changes shape of 30S subunit

17. Inhibitors of Protein Synthesis

18. Inhibitors of Protein Synthesis
 Streptogramins
 Gram-positives
 Binds 50S subunit; inhibits translation

19. Inhibitors of Protein Synthesis

20. Inhibitors of Protein Synthesis
 Oxazolidinones
 Linezolid
 Gram-positives
 Binds 50S subunit; prevents formation of 70S ribosome

21. Inhibitors of Nucleic Acid Synthesis
 Rifamycin
 Inhibits RNA synthesis
 Antituberculosis
 Quinolones and fluoroquinolones
 Nalidixic acid: Urinary infections
 Ciprofloxacin
 Inhibits DNA gyrase
 Urinary tract infections

22. Quinolones
 Strong, rapid bactericidal action against most gram-
negative and many gram-positive bacteria
 Antagonize the enzyme responsible for coiling and
replicating DNA, causing DNA breakage and cell
death
Quinolones’ Dispensing Issues
 Not to be given with theophylline
 Antacids interfere with absorption
 Avoid exposure to sun

23. Therapeutic Uses of Quinolones
 Bone and joint infections caused by gram-negative
organisms
 Infectious diarrhea
 Ophthalmic infections
 Some sexually transmitted diseases
 Upper respiratory infections
 UTIs

24. Quinolones’ Side Effects
 Primarily gastrointestinal, with nausea and vomiting
 Dizziness
 Unpleasant taste
 Can cause joint problems such as swelling and
malformations
 Patients taking them have a tendency to injure
tendons

25. Rifamycin
 any of a family of antibiotics biosynthesized by a strain
of Streptomyces mediterranei, effective against a broad
spectrum of bacteria, including gram-positive cocci,
some gram-negative bacilli, and Mycobacterium
tuberculosis and certain other mycobacteria; used for
the treatment of tuberculosis and the prophylaxis of
meningococcal infections.

26. Adverse reactions
 CNS: ataxia, confusion, drowsiness, fatigue, headache, asthenia, psychosis,
generalized numbness
 EENT: conjunctivitis; discolored tears, saliva, and sputum
 GI: nausea, vomiting, diarrhea, abdominal cramps, dyspepsia, epigastric
distress, flatulence, discolored feces, anorexia, sore mouth and
tongue, pseudomembranous colitis
 GU: discolored urine
 Hematologic: eosinophilia, transient leukopenia , hemolytic anemia,
hemolysis, disseminated intravascular coagulation (DIC),
thrombocytopenia
 Hepatic: jaundice
 Metabolic: hyperuricemia
 Musculoskeletal: myalgia, joint pain
 Respiratory: dyspnea, wheezing
 Skin: flushing, rash, pruritus, discolored sweat, erythema multiforme, toxic
epidermal necrolysis, Stevens-Johnson syndrome Other: flulike
symptoms, hypersensitivity reactions including vasculitis

27. prophylaxis refers to medical or public health
measures taken in order to prevent disease or health
problems, rather than to treat or cure an existing
condition. Prophylaxis is also a way to stem an
outbreak of disease, or minimize the symptoms of
someone who has been exposed to a disease or virus.